Brief: Takeda Pharmaceutical's Qdenga (Tak-003) Becomes First Dengue Vaccine To Be Approved In India- Statement
20/07/2026 06:45
BRIEF-Takeda Pharmaceutical's Qdenga (Tak-003) Becomes First Dengue Vaccine To Be Approved In India- Statement July 20 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:
TAKEDA PHARMACEUTICAL'S QDENGA (TAK-003) BECOMES FIRST DENGUE VACCINE TO BE APPROVED IN INDIA- STATEMENT
Further company coverage: 4502.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)